No information is available on the clinical use of rimegepant during breastfeeding. However, amounts in breastmilk are low and would not be expected to cause any adverse effects in breastfed infants. If rimegepant is required by the mother of an older infant, it is not a reason to discontinue breastfeeding, but until more data become available, an alternate drug may be preferred while nursing a newborn or preterm infant.
CITATION STYLE
Negro, A. (2022). Rimegepant (pp. 51–66). https://doi.org/10.1007/978-3-030-95334-8_5
Mendeley helps you to discover research relevant for your work.